BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lim Z, Welman CJ, Raymond W, Thin L. The Effect of Adiposity on Anti-Tumor Necrosis Factor-Alpha Levels and Loss of Response in Crohn's Disease Patients. Clin Transl Gastroenterol 2020;11:e00233. [PMID: 33094963 DOI: 10.14309/ctg.0000000000000233] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Tassone D, Singh S, Sheng Ding N. Editorial: impact of body mass index on clinical outcomes in patients with ulcerative colitis treated with tofacitinib. Aliment Pharmacol Ther 2021;54:206-7. [PMID: 34170531 DOI: 10.1111/apt.16456] [Reference Citation Analysis]
2 Yueying C, Jing F, Tian Y, Yuqi Q, Jun S. Bioelectrical impedance analysis-based nomogram construction for predicting secondary loss of response to infliximab in bio-naïve Crohn's disease patients. Biomed Pharmacother 2021;142:112076. [PMID: 34449314 DOI: 10.1016/j.biopha.2021.112076] [Reference Citation Analysis]
3 Bassi M, Singh S. Impact of Obesity on Response to Biologic Therapies in Patients with Inflammatory Bowel Diseases. BioDrugs 2022. [PMID: 35320515 DOI: 10.1007/s40259-022-00522-0] [Reference Citation Analysis]
4 Gu P, Dube S, McGovern DPB. Medical and Surgical Implications of Mesenteric Adipose Tissue in Crohn's Disease: A Review of the Literature. Inflamm Bowel Dis 2022:izac120. [PMID: 35731568 DOI: 10.1093/ibd/izac120] [Reference Citation Analysis]
5 Ando K, Uehara K, Sugiyama Y, Kobayashi Y, Murakami Y, Sato H, Kunogi T, Sasaki T, Takahashi K, Ueno N, Kashima S, Moriichi K, Tanabe H, Okumura T, Fujiya M. Correlation Among Body Composition Parameters and Long-Term Outcomes in Crohn's Disease After Anti-TNF Therapy. Front Nutr 2022;9:765209. [DOI: 10.3389/fnut.2022.765209] [Reference Citation Analysis]
6 Gu P, Chhabra A, Chittajallu P, Chang C, Mendez D, Gilman A, Fudman DI, Xi Y, Feagins LA. Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy. Inflamm Bowel Dis 2021:izab167. [PMID: 34291800 DOI: 10.1093/ibd/izab167] [Reference Citation Analysis]